
Consider CoreMedics (CRMD) as a high-conviction opportunity, with the analyst stating it remains "extremely cheap" even after a 17% gain driven by strong revenue and an analyst upgrade. The speaker believes the stock "had no business getting below $10" and has significant growth potential. As a popular proxy for Bitcoin, MicroStrategy (MSTR) is viewed as a bullish investment with a potential future price target above $400. This outlook is supported by Bitcoin (BTC) itself, which is rebounding strongly from a period of 'extreme fear,' suggesting the recent lows may have presented a buying opportunity. Lastly, fintech stock SoFi (SOFI) is showing positive momentum as it appears to be breaking out of its long-term trading range.

By @BeatTheDenominator